V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012712 | 240008927 | null | 94.2 | Palliative (P) | 2015-08-01 | 2015-10-30 | ICE-R | 2 | N | 240024118 | R CODOX M |
| 240012713 | 240008928 | null | 85.4 | Curative (C) | null | 2016-08-05 | FLUDARABINE | N | null | 240024570 | CHLVPP |
| 240012714 | 240014569 | 1.8 | 113 | Curative (C) | 2016-02-03 | 2016-02-04 | R-GEM-P | N | N | 240024570 | GEMCITABINE + PACLITAXEL |
| 240012715 | 240008930 | 1.53 | 70 | Palliative (P) | 2013-09-01 | 2013-09-01 | Carboplatin + Docetaxel | 2 | N | 240025020 | TRABECTEDIN |
| 240012716 | 240008930 | 1.55 | 50.2 | Curative (C) | 2016-05-29 | 2016-05-29 | CYTARABINE + ETOPOSIDE | 2 | N | 240025020 | R CODOX M |
| 240012717 | 240008930 | 1.62 | 64.1 | Palliative (P) | 2018-07-23 | 2018-08-31 | MABCUTE TRIAL | N | N | 240025020 | CISPLATIN + FLUOROURACIL |
| 240012718 | 240008931 | 1.62 | 82.3 | Palliative (P) | 2019-06-05 | 2019-06-05 | ICE (no GCSF) | 02 | null | 240025194 | IPM |
| 240012719 | 240008932 | 1.77 | 83 | Disease modification (D) | null | 2017-01-05 | BEAM + FLUDARABINE | null | null | 240025383 | R-CHOEP |
| 240012720 | 240008933 | 1.75 | 84.8 | null | 2017-10-19 | 2017-10-23 | Cytarabine HD + Methotrexate HD | 02 | N | 240025437 | BLEOMYCIN + CHLORAMBUCIL + LOMUSTINE + METHOTREXATE + RITUXIMAB + VINBLASTINE |
| 240012721 | 240008934 | 1.62 | 58.5 | Curative (C) | 2016-05-02 | 2016-05-03 | Topotecan (intravenous) | 2 | N | 240025468 | REMODL TRIAL |
| 240012722 | 240008935 | null | 52.8 | Disease modification (D) | 2016-01-20 | 2016-01-21 | PEMBROLIZUMAB | N | N | 240025582 | CAPECITABINE + OXALIPLATIN |
| 240012723 | 240015472 | 1.6 | 54.4 | Disease modification (D) | null | 2017-01-08 | CRIZOTINIB | N | null | 240025641 | CISPLATIN + FLUOROURACIL |
| 240012724 | 240012777 | 1.82 | null | Palliative (P) | 2018-09-21 | 2018-09-29 | RCEOP | N | N | 240025641 | PIXANTRONE |
| 240012725 | 240012777 | 1.72 | 97.8 | Palliative (P) | 2018-12-19 | 2018-12-21 | IVAC | 2 | N | 240025641 | AML17 TRIAL |
| 240012726 | 240015935 | 1.66 | 64.8 | Palliative (P) | 2013-09-29 | 2013-10-01 | CISPLATIN + GEMCITABINE | N | null | 240026056 | ETOPOSIDE |
| 240012727 | 240008939 | 0 | 0 | Curative (C) | 2014-08-12 | 2014-08-18 | R-PMitCEBOM | 2 | N | 240026078 | MATRIX TRIAL |
| 240012728 | 240008941 | 1.55 | 77.6 | Disease modification (D) | 2017-02-21 | 2017-02-26 | DA-EPOCH-R | N | N | 240026165 | CODOX M |
| 240012729 | 240008942 | null | 51.6 | Palliative (P) | 2016-12-17 | 2016-12-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 240026266 | GEMCITABINE + OXALIPLATIN |
| 240012730 | 240008943 | 1.64 | 78 | Not known (9) | 2013-12-28 | 2013-12-29 | VEDex | 2 | N | 240026776 | CARBOPLATIN + TOPOTECAN |
| 240012731 | 240008943 | 1.78 | 90.4 | Disease modification (D) | 2015-08-03 | 2016-10-09 | Fludarabine oral | 02 | N | 240026776 | GEMCITABINE + OXALIPLATIN |
| 240012732 | 240008943 | 1.71 | 67 | Curative (C) | 2017-02-10 | 2017-02-10 | Vincristine (weekly) | N | N | 240026776 | CYTARABINE + METHOTREXATE |
| 240012733 | 240015936 | 1.58 | 46.8 | Curative (C) | 2017-06-25 | 2017-06-25 | Triple / Double Intrathecal Therapy | N | null | 240027348 | RUXOLITINIB |
| 240012734 | 240008944 | 1.58 | 82.8 | Palliative (P) | 2018-10-05 | 2018-10-10 | Vinorelbine IV | 02 | N | 240027620 | RCEOP |
| 240012735 | 240012779 | 1.65 | 55.4 | Disease modification (D) | 2014-04-22 | 2014-06-03 | Bendamustine + Obinutuzumab | N | N | 240027765 | UKALL60+ |
| 240012736 | 240008946 | 1.7 | 76.2 | null | 2016-10-29 | 2016-10-30 | IVE | 01 | N | 240027838 | ICE |
| 240012737 | 240008947 | 1.63 | null | Palliative (P) | null | 2014-06-08 | Sorafenib | N | N | 240027921 | IMATINIB |
| 240012738 | 240008947 | 1.76 | 133.6 | Disease modification (D) | 2018-02-09 | 2018-02-09 | R-CHOEP | N | null | 240027921 | GEMCITABINE + OXALIPLATIN |
| 240012739 | 240008949 | 1.73 | 0 | Curative (C) | 2018-02-25 | 2018-02-26 | CISPLATIN + GEMCITABINE | N | N | 240028008 | VINORELBINE |
| 240012740 | 240008950 | 1.65 | 95.5 | null | null | 2015-01-01 | PONATINIB | null | N | 240028013 | TOPOTECAN |
| 240012741 | 240008951 | null | null | Palliative (P) | 2016-04-05 | 2016-04-19 | Cisplatin + Paclitaxel | N | N | 240028056 | IRINOTECAN + MDG |
| 240012742 | 240008952 | 1.65 | 55 | Palliative (P) | 2016-01-10 | 2016-01-10 | BENDAMUSTINE + BORTEZOMIB | 02 | N | 240028346 | CAV |
| 240012743 | 240008954 | 1.8 | 61.6 | Disease modification (D) | 2016-10-16 | 2017-01-20 | Cladribine IV (5 day) | 2 | N | 240028501 | IVAC |
| 240012744 | 240008954 | 1.74 | 75.9 | null | 2016-08-12 | 2016-08-13 | DACTINOMYCIN + CYCLO + VINCRISTINE | 2 | N | 240028501 | TRIFLURIDINE + TIPIRACIL |
| 240012745 | 240008955 | 1.76 | 90.4 | Disease modification (D) | 2016-12-10 | 2016-12-24 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | N | N | 240028692 | OXALIPLATIN + RALTITREXED |
| 240012746 | 240008956 | 1.7 | null | Palliative (P) | null | 2018-09-30 | FLUDARABINE | null | N | 240028943 | CAPECITABINE + OXALIPLATIN |
| 240012747 | 240008957 | 0 | 74.8 | Curative (C) | 2014-12-24 | 2014-12-25 | ICE-R | 2 | N | 240028966 | UKALL2014 |
| 240012748 | 240015476 | 1.7 | 64.35 | Palliative (P) | 2015-08-12 | 2016-09-13 | PMitCEBO-R | 02 | N | 240029117 | IVE |
| 240012749 | 240008958 | 1.79 | null | Palliative (P) | 2017-03-06 | 2017-03-18 | CISPLATIN + GEMCITABINE | N | N | 240029335 | RCEOP |
| 240012750 | 240008959 | 1.64 | 78 | Disease modification (D) | null | 2015-11-27 | Doxorubicin + Olaratumab | 02 | N | 240029679 | IRINOTECAN + MDG |
| 240012751 | 240008959 | 1.52 | 62.6 | Curative (C) | 2016-10-10 | 2017-05-25 | CISPLATIN + FLUOROURACIL + RT | N | N | 240029679 | IRINOTECAN + MDG |
| 240012752 | 240008961 | null | 41.9 | Disease modification (D) | 2013-09-21 | 2013-10-02 | DHAP - R | N | N | 240029722 | FEC |
| 240012753 | 240008961 | 1.63 | 57.8 | Curative (C) | 2018-01-16 | 2018-01-16 | ALL UKALL60+ TRIAL | 02 | N | 240029722 | ICE-R |
| 240012754 | 240008962 | 1.52 | 76.6 | Curative (C) | 2017-01-29 | 2017-09-05 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | N | 240029940 | DOXORUBICIN |
| 240012755 | 240012789 | 1.58 | 59.7 | Palliative (P) | 2016-10-16 | 2016-11-20 | Carboplatin + Docetaxel | Y | N | 240029942 | GALLIUM TRIAL |
| 240012756 | 240012789 | 1.69 | 83 | Curative (C) | 2016-06-06 | 2016-07-12 | AML 19 TRIAL | N | N | 240029942 | CYTARABINE HD + METHOTREXATE HD |
| 240012757 | 240008964 | null | null | Palliative (P) | 2014-01-16 | 2014-01-17 | Oxaliplatin + Modified de Gramont | N | N | 240030314 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 240012758 | 240008965 | 1.64 | null | Curative (C) | 2017-06-16 | 2017-06-21 | CYTARABINE + METHOTREXATE | N | null | 240030380 | BEVACIZUMAB + CARBO |
| 240012759 | 240008965 | 1.61 | 45.3 | Adjuvant (A) | 2017-02-27 | 2017-02-27 | Gemcitabine + Oxaliplatin | 2 | N | 240030380 | DHAP - R |
| 240012760 | 240008967 | 1.64 | 57 | Neo-adjuvant (N) | 2018-10-14 | 2018-10-15 | GALLIUM TRIAL | 2 | N | 240030535 | TOPOTECAN |
| 240012761 | 240008968 | 1.69 | 56 | Palliative (P) | 2017-12-19 | 2017-12-19 | IVAC | 2 | N | 240030629 | TOPOTECAN |